Behavioral and Neural Representations of Subjective Effort Cost

January 23, 2026 updated by: Vikram Chib, Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
The goal of this proposal is to understand the common and distinct behavioral and neural representations of subjective effort valuation, and how these representations are influenced by fatigue and changes in motivation. It is hypothesized that the brain will use overlapping and distinct neural circuits to represent cognitive and physical effort value, and that fatigue and enhanced motivation will influence the subjective value of effort.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

How effortful a task feels is an integral aspect of human decision-making that shapes motivation. If a task feels very effortful one may be unwilling to perform the work required, whereas if a task feels less effortful one may be more likely to persevere. Despite the importance of these perceptions for decision-making, the behavioral and neural mechanisms of subjective effort valuation are not well understood. Furthermore, the National Institutes of Mental Health (NIMH) Research Domain Criteria (RDoC) has identified "Effort Valuation / Willingness to Work" as a key subconstruct for understanding deficits in motivated performance in mental disorders. The goal of this proposal is to understand the mechanisms of subjective valuation of physical and cognitive effort, and the common and distinct systems that underlie these representations. To this end, a combination of experiments in healthy human participants, computational modeling of behavior, and functional magnetic resonance imaging (fMRI) will be used. Aim 1 will identify common and distinct physical and cognitive effort valuation mechanisms. Computational models will be used to characterize participants' subjective valuation of physical and cognitive effort, and to test if there are similarities in subjective preferences for these different types of effort. Model-based fMRI will be used to examine the common and distinct brain regions that encode the subjective valuation of physical and cognitive effort, and the network of brain regions that incorporate such preferences to motivate effortful engagement. Aim 2 will investigate the behavioral and neural mechanisms by which physical and cognitive fatigue effect effort valuation. Participants will be fatigued with sustained physical or cognitive exertion to examine how being in a fatigued state influences subjective valuation of physical and cognitive effort; and associated signals in the brain's valuation network. Aim 3 will explore how motivational state modulates decisions to exert physical and cognitive effort. Choices for physical and cognitive effort will be paired with motivational cues (i.e., cues that formerly predicted reward) in order to modulate participants' motivational state. This manipulation will allow for behavioral and neural dissociations between motivation and effort valuation in order to understand how these processes interact to give rise to motivated physical and cognitive engagement. In sum, the proposed studies will have a broad impact on the field of decision-making by dissecting the behavioral and neural mechanisms responsible for physical and cognitive effort valuation. In the long term, these studies may reveal novel behavioral and neural markers to aid in the study, classification, and treatment of amotivation.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
185

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Right-handed
  • Age between 18 and 35 years old - Male or female
  • Any ethnicity

Exclusion Criteria:

Individuals with a history of any of the following will be excluded from the study:

  • Neurological problems such as stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease (self- report)
  • Diagnosed history of severe psychiatric disease such as depression, schizophrenia (self-report)
  • Metal in the head or eyes
  • If they are pregnant or suspect that you may be pregnant
  • If they experience discomfort from the MRI scan, such as severe claustrophobia or excessive heating of tattoos

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Cognitive Fatigue
We will use a behavioral intervention. Participants will perform a cognitively demanding task, repeatedly, to induce cognitive fatigue.
Behavioral: Cognitive Fatigue
Participants will perform a cognitively demanding task (spatial attention task), repeatedly, to induce cognitive fatigue.
Experimental: Physical Fatigue
We will use a behavioral intervention. Participants will perform a physically demanding task (grip force exertion task), repeatedly, to induce cognitive fatigue.
Behavioral: Physical Fatigue
Participants will perform a physically demanding task (grip force exertion task), repeatedly, to induce cognitive fatigue.
Experimental: Rewarding Stimuli
We will use a behavioral intervention. Reward-associated stimuli will be used to study how reward-induced changes in motivational state influence effort choices.
Behavioral: Rewarding Stimuli
Reward-associated stimuli will be used to study how reward-induced changes in motivational state influence effort choices.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Mean of cognitive subjective effort parameters (from behavioral choice data)
Time Frame: 1 day
Choice data will be fit to a model of the form u(x) = x^rho. The parameter rho is indicative of individuals' subjective preferences for effort. We will test if participants cognitive subjective effort parameters will be significantly different than zero. Effort levels will be expressed as a percentage of each individual's maximum exertion capacity. This will ensure that comparisons can be made between participants.
1 day
Differences between cognitive subjective effort parameters before and after fatigue (from behavioral choice data)
Time Frame: 1 day
Choice data will be fit to a model of the form u(x) = x^rho. The parameter rho is indicative of individuals' subjective preferences for effort. We will test if participants cognitive subjective effort parameters will be significantly different when comparing parameters extracted from pre-fatigue and post-fatigue choices. Effort levels will be expressed as a percentage of each individual's maximum exertion capacity. This will ensure that comparisons can be made between participants.
1 day
Mean of physical subjective effort parameters (from behavioral choice data)
Time Frame: 1 days
Choice data will be fit to a model of the form u(x) = x^rho. The parameter rho is indicative of individuals' subjective preferences for effort. We will test if participants physical subjective effort parameters will be significantly different than zero. Effort levels will be expressed as a percentage of each individual's maximum exertion capacity. This will ensure that comparisons can be made between participants.
1 days
Differences between physical subjective effort parameters before and after fatigue (from behavioral choice data)
Time Frame: 1 day
Choice data will be fit to a model of the form u(x) = x^rho. The parameter rho is indicative of individuals' subjective preferences for effort. We will test if participants physical subjective effort parameters will be significantly different when comparing parameters extracted from pre-fatigue and post-fatigue choices. Effort levels will be expressed as a percentage of each individual's maximum exertion capacity. This will ensure that comparisons can be made between participants.
1 day
Difference between cognitive effort cost parameters between the low and high reward stimuli
Time Frame: 1 day
Choice data will be fit to a model of the form u(x) = x^rho. The parameter rho is indicative of individuals' subjective preferences for effort. We will test if participants subjective effort parameters will be significantly different when comparing parameters extracted from low and high reward stimuli trials. Effort levels will be expressed as a percentage of each individual's maximum exertion capacity. This will ensure that comparisons can be made between participants.
1 day
Difference between physical effort cost parameters between the low and high reward stimuli
Time Frame: 1 day
Choice data will be fit to a model of the form u(x) = x^rho. The parameter rho is indicative of individuals' subjective preferences for effort. We will test if participants subjective effort parameters will be significantly different when comparing parameters extracted from low and high reward stimuli trials. Effort levels will be expressed as a percentage of each individual's maximum exertion capacity. This will ensure that comparisons can be made between participants.
1 day
Regions of the brain encoding cognitive effort
Time Frame: 1 day
We will use a general linear model to examine brain activity that is positively and negatively correlated with chosen cognitive effort value.
1 day
Regions of the brain encoding physical effort
Time Frame: 1 day
We will use a general linear model to examine brain activity that is positively and negatively correlated with chosen physical effort value.
1 day
Regions of the brain encoding changes cognitive effort value following cognitive fatigue
Time Frame: 1 day
We will use a general linear model to examine brain activity that is positively and negatively correlated with fatigue-induced changes in cognitive effort value.
1 day
Regions of the brain encoding changes physical effort value following physical fatigue
Time Frame: 1 day
We will use a general linear model to examine brain activity that is positively and negatively correlated with fatigue-induced changes in physical effort value.
1 day
Regions of the brain encoding differences in cognitive effort value resulting from reward-induced changes in motivation
Time Frame: 1 day
We will use a general linear model to examine brain activity that is positively and negatively correlated with motivation-induced changes in cognitive effort value.
1 day
Regions of the brain encoding differences in physical effort value resulting from reward-induced changes in motivation
Time Frame: 1 day
We will use a general linear model to examine brain activity that is positively and negatively correlated with motivation-induced changes in physical effort value.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
National Institute of Mental Health (NIMH)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Vikram S. Chib, PhD, Kennedy Krieger Institute and Johns Hopkins School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 1, 2018

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2029

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2029

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 26, 2019

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 30, 2019

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 1, 2019

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 26, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 23, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IRB00283000
  • 1R56MH113627-01A1 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings